Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.66
+0.07 (0.52%)
At close: May 8, 2026, 4:00 PM EDT
14.09
+0.43 (3.15%)
After-hours: May 8, 2026, 7:33 PM EDT
Generate Biomedicines Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$25.00
Upside
+83.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $25 | Strong Buy | Maintains | $16 → $25 | +83.02% | May 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +17.13% | Apr 13, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +90.34% | Mar 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +46.41% | Mar 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $24 | Buy | Initiates | $24 | +75.70% | Mar 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +119.62% | Mar 24, 2026 |